REBECCA LALIBERTE: Open Payments
NPI 1316535982 · PORTSMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $721
Food & beverage: $621Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $284 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| ABBVIE INC. | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Organon LLC | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Amgen Inc. | 1 | $29 |
| Galderma Laboratories, L.P. | 2 | $29 |
| Incyte Corporation | 1 | $25 |
Products named: TREMFYA, Rhapsido, DUPIXENT, RINVOQ, SKYRIZI, Leqselvi, Sotyktu, OTEZLA.
Industry payments across NH — which companies pay providers there.
